Ipca Laboratories Financials
NSE: IPCALAB | BSE: 524494
₹1,927.00
As on 30-Sep-2026 15:31IST
Market cap
₹49,281 Cr
Revenue (TTM)
₹10,126 Cr
P/E Ratio
37.6
P/B Ratio
5.8
Div. Yield
0.3 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
10,125.58
|
9,599.02
|
8,896.81
|
7,662.43
|
6,204.26
|
5,796.74
|
|||||
|
Total Income
|
10,292.63
|
9,800.71
|
9,048.13
|
7,846.79
|
6,356.03
|
5,918.46
|
|||||
|
Total Expenditure
|
7,893.93
|
7,644.55
|
7,226.28
|
6,398.38
|
5,300.99
|
4,539.12
|
|||||
|
EBITDA
|
2,231.65
|
1,954.47
|
1,670.53
|
1,264.05
|
903.27
|
1,257.62
|
|||||
|
Depreciation
|
428.87
|
418.12
|
397.82
|
357.24
|
261.56
|
232.42
|
|||||
|
EBIT
|
1,802.78
|
1,536.35
|
1,272.71
|
906.81
|
641.71
|
1,025.20
|
|||||
|
Interest
|
69.31
|
79.09
|
87.84
|
140.75
|
48.19
|
11.20
|
|||||
|
Other Income
|
167.05
|
201.69
|
151.32
|
184.36
|
151.77
|
121.72
|
|||||
|
Exceptional Items
|
-86.43
|
-86.43
|
-205.05
|
-107.75
|
--
|
--
|
|||||
|
Profit before Tax
|
1,814.09
|
1,572.52
|
1,131.14
|
842.67
|
745.29
|
1,135.72
|
|||||
|
Provision for Tax
|
434.33
|
381.15
|
343.61
|
313.46
|
253.36
|
224.77
|
|||||
|
Profit after Tax
|
1,379.76
|
1,191.37
|
787.53
|
529.21
|
491.93
|
910.95
|
|||||
|
Minority Interest
|
-65.36
|
-42.66
|
-47.56
|
24.43
|
-7.67
|
-5.71
|
|||||
|
Share of Associate
|
-4.60
|
-7.59
|
-2.29
|
-6.29
|
-12.94
|
-21.16
|
|||||
|
Consolidated Profit
|
1,309.80
|
1,141.12
|
737.68
|
547.35
|
471.32
|
884.08
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,063.81
|
8,063.81
|
6,948.45
|
6,332.19
|
5,842.02
|
5,464.84
|
|||||
|
Minority Interest
|
-65.36
|
1,460.25
|
1,439.82
|
1,394.81
|
73.30
|
76.92
|
|||||
|
Non-Current Liabilities
|
539.20
|
518.66
|
969.14
|
1,014.41
|
901.72
|
613.87
|
|||||
|
Current Liabilities
|
2,306.93
|
2,306.93
|
2,384.29
|
2,355.64
|
1,805.82
|
1,465.88
|
|||||
|
Total Liabilities
|
12,370.19
|
12,349.65
|
11,743.63
|
11,097.05
|
8,622.86
|
7,621.51
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
5,384.61
|
5,972.79
|
5,475.09
|
5,558.15
|
3,433.59
|
3,164.34
|
|||||
|
Current Assets
|
6,373.61
|
6,373.61
|
5,967.04
|
5,535.55
|
5,189.27
|
4,446.71
|
|||||
|
Total Assets
|
12,370.19
|
12,349.65
|
11,743.63
|
11,097.05
|
8,622.86
|
7,621.51
|
|||||
|
Total Debt*
|
--
|
703.94
|
1,301.70
|
1,387.50
|
1,457.53
|
791.24
|
|||||
|
Net Current Assets
|
4,066.68
|
4,066.68
|
3,582.75
|
3,179.91
|
3,383.45
|
2,980.83
|
|||||
|
Contingent Liabilities
|
--
|
249.19
|
234.86
|
119.12
|
93.44
|
69.67
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,141.97
|
1,321.32
|
944.65
|
805.81
|
856.07
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-246.77
|
-869.50
|
-1,291.79
|
-725.00
|
-855.05
|
|||||
|
Cash from Financing Activities
|
--
|
-753.53
|
-282.98
|
-552.55
|
507.24
|
426.78
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
141.67
|
168.84
|
-899.69
|
588.05
|
427.80
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
54.11
|
44.98
|
29.08
|
21.57
|
18.58
|
34.85
|
|||||
|
Cash EPS (₹)
|
51.63
|
63.44
|
46.72
|
34.94
|
29.70
|
45.07
|
|||||
|
Adjusted Book Value (₹)
|
334.38
|
317.72
|
273.78
|
249.53
|
230.27
|
215.41
|
|||||
|
Dividend per Share (₹)
|
0.31
|
6.00
|
4.00
|
4.00
|
4.00
|
4.00
|
|||||
|
Cash Flow per Share (₹)
|
--
|
45.01
|
52.08
|
37.23
|
31.76
|
33.74
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
26.00
|
9.20
|
15.12
|
12.14
|
15.44
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
19.41
|
15.27
|
13.10
|
11.71
|
20.46
|
|||||
|
ROE (%)
|
17.72
|
15.88
|
11.86
|
8.70
|
8.70
|
17.92
|
|||||
|
ROA (%)
|
11.44
|
9.89
|
6.90
|
5.37
|
6.06
|
13.31
|
|||||
|
EBIT Margin (%)
|
17.80
|
16.01
|
14.31
|
11.83
|
10.34
|
17.69
|
|||||
|
Net Margin (%)
|
13.41
|
12.16
|
8.70
|
6.74
|
7.74
|
15.39
|
|||||
|
Cash Profit Margin (%)
|
--
|
16.69
|
13.26
|
11.50
|
12.07
|
19.61
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
10.59
|
7.89
|
16.11
|
23.50
|
7.03
|
7.45
|
|||||
|
EBIT Growth (%)
|
33.46
|
20.71
|
40.35
|
41.31
|
-37.41
|
-19.41
|
|||||
|
Net Profit Growth (%)
|
54.72
|
51.28
|
48.81
|
7.58
|
-46.00
|
-20.71
|
|||||
|
EPS Growth (%)
|
68.21
|
54.69
|
34.77
|
16.13
|
-46.69
|
-22.45
|
|||||
|
Book Value Growth (%)
|
--
|
16.05
|
9.72
|
8.36
|
6.90
|
16.23
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
37.62
|
35.64
|
51.63
|
57.39
|
43.62
|
30.45
|
|||||
|
Price / Book Value
|
5.81
|
5.05
|
5.48
|
4.96
|
3.52
|
4.93
|
|||||
|
Dividend Yield (%)
|
0.31
|
0.37
|
0.27
|
0.32
|
0.49
|
0.38
|
|||||
|
EV/EBITDA
|
20.60
|
18.93
|
21.43
|
22.44
|
19.11
|
19.63
|
|||||
|
Close Price (₹)
|
1,701.00
|
1,601.20
|
1,501.90
|
1,237.40
|
810.35
|
1,065.75
|
|||||
|
High Price (₹)
|
1,736.00
|
1,624.00
|
1,757.65
|
1,264.00
|
1,065.00
|
1,383.55
|
|||||
|
Low Price (₹)
|
1,251.60
|
1,168.20
|
1,052.00
|
669.80
|
767.50
|
916.68
|
|||||
|
Market Cap (₹ Cr)
|
49,280.78
|
40,668.17
|
38,088.13
|
31,414.43
|
20,557.20
|
26,921.22
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.09
|
0.19
|
0.22
|
0.25
|
0.14
|
|||||
|
Short term debt to equity ratio
|
--
|
0.05
|
0.07
|
0.09
|
0.11
|
0.07
|
|||||
|
Current Ratio
|
2.76
|
2.76
|
2.50
|
2.35
|
2.87
|
3.03
|
|||||
|
Quick Ratio
|
1.58
|
1.58
|
1.43
|
1.30
|
1.91
|
1.77
|
|||||
|
Interest Coverage
|
27.17
|
20.88
|
13.88
|
6.99
|
16.47
|
102.40
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.89
|
20.98
|
21.18
|
22.01
|
15.94
|
15.71
|
|||||
|
Asset Turnover
|
0.84
|
0.80
|
0.78
|
0.78
|
0.77
|
0.85
|
|||||
|
Receivable days
|
--
|
73.75
|
72.89
|
63.37
|
55.52
|
53.92
|
|||||
|
Inventory Days
|
--
|
100.11
|
102.72
|
99.83
|
105.25
|
108.09
|
|||||
|
Payable days
|
--
|
131.14
|
121.11
|
102.19
|
86.04
|
111.16
|
|||||
|
Cash Conversion Cycle
|
--
|
42.73
|
54.51
|
61.01
|
74.74
|
50.86
|